Prevalence and mechanisms of antimicrobial resistance in samples of surveillance swabs from patients in a hospital unit in Nova Prata, RS

Detalhes bibliográficos
Autor(a) principal: Cerato Todescatto, Genara
Data de Publicação: 2023
Outros Autores: Lago Salame, Alessandra, Dalzochio, Thaís
Tipo de documento: Artigo
Idioma: por
Título da fonte: Saúde (Santa Maria)
Texto Completo: https://periodicos.ufsm.br/revistasaude/article/view/71277
Resumo: Objective: To analyze the prevalence and the mechanisms of antimicrobial resistance of isolated bacteria (rectal, nasal and skin samples) of patients in a hospital unit in the city of Nova Prata, RS. Methods: Data were collected from 377 reports from the Serviço de Controle de Infecção Hospitalar (SCIH) issued between January 2018 and December 2021 available in the electronic system of a clinical analysis laboratory located in Nova Prata, RS. Data included the year of sample collection, sample type, microorganisms isolated and their resistance mechanisms. Reports that contained information regarding the initiation of the patient's treatment with antimicrobials were excluded. Results: Overall, the prevalence of positive cases corresponding to isolated bacteria was 39.8% (150/377) over the entire study period. The lowest and highest rates were verified in the years 2018 and 2020, respectively, and in 2018, no sample analyzed was positive. In 2019, 44% (4/9) of the samples were positive, and the Klebsiella pneumoniae carbapenemase (KPC) was the most prevalent, being isolated from 75% of the positive samples (3/4). In 2020, 43% (53/122) of the samples were positive, with the Escherichia coli producer of β-lactamases of extended-spectrum (ESBL) present in 32% (17/53), followed by Enterobacter cloacae ESBL and K. pneumoniae carbapenemase. In the year 2021, 40% (93/230) of the samples had a positive result, and the E. coli ESBL was the most prevalent, present in 57% (53/93) of positive samples. Finally, a higher prevalence of positive samples collected from the rectal and skin sites was found. Final considerations: The present study showed an increase in resistant bacteria in 2020 and 2021, which coincides with the covid-19 pandemic. Thus, it is essential to implement procedures that contribute to improving the control of resistant microorganisms in the municipality.
id UFSM-14_350fb82eed33622475f12795f758f744
oai_identifier_str oai:ojs.pkp.sfu.ca:article/71277
network_acronym_str UFSM-14
network_name_str Saúde (Santa Maria)
repository_id_str
spelling Prevalence and mechanisms of antimicrobial resistance in samples of surveillance swabs from patients in a hospital unit in Nova Prata, RSPREVALÊNCIA E MECANISMOS DE RESISTÊNCIA ANTIMICROBIANA EM AMOSTRAS DE SWABS DE VIGILÂNCIA DE PACIENTES INTERNADOS EM UMA UNIDADE HOSPITALAR DE NOVA PRATA, RSAntimicrobialsHospital InfectionBacterial ResistanceAntimicrobianosInfecção HospitalarResistência bacterianaObjective: To analyze the prevalence and the mechanisms of antimicrobial resistance of isolated bacteria (rectal, nasal and skin samples) of patients in a hospital unit in the city of Nova Prata, RS. Methods: Data were collected from 377 reports from the Serviço de Controle de Infecção Hospitalar (SCIH) issued between January 2018 and December 2021 available in the electronic system of a clinical analysis laboratory located in Nova Prata, RS. Data included the year of sample collection, sample type, microorganisms isolated and their resistance mechanisms. Reports that contained information regarding the initiation of the patient's treatment with antimicrobials were excluded. Results: Overall, the prevalence of positive cases corresponding to isolated bacteria was 39.8% (150/377) over the entire study period. The lowest and highest rates were verified in the years 2018 and 2020, respectively, and in 2018, no sample analyzed was positive. In 2019, 44% (4/9) of the samples were positive, and the Klebsiella pneumoniae carbapenemase (KPC) was the most prevalent, being isolated from 75% of the positive samples (3/4). In 2020, 43% (53/122) of the samples were positive, with the Escherichia coli producer of β-lactamases of extended-spectrum (ESBL) present in 32% (17/53), followed by Enterobacter cloacae ESBL and K. pneumoniae carbapenemase. In the year 2021, 40% (93/230) of the samples had a positive result, and the E. coli ESBL was the most prevalent, present in 57% (53/93) of positive samples. Finally, a higher prevalence of positive samples collected from the rectal and skin sites was found. Final considerations: The present study showed an increase in resistant bacteria in 2020 and 2021, which coincides with the covid-19 pandemic. Thus, it is essential to implement procedures that contribute to improving the control of resistant microorganisms in the municipality.Objetivo: Analisar a prevalência e os mecanismos de resistência antimicrobiana de bactérias isoladas em amostras (das regiões retal, nasal e pele) de pacientes internados em uma unidade hospitalar de Nova Prata, RS. Métodos: Foram coletados dados de 377 laudos do Serviço de Controle de Infecção Hospitalar (SCIH) emitidos entre janeiro de 2018 e dezembro de 2021 disponíveis no sistema eletrônico de um laboratório de análises clínicas localizado em Nova Prata, RS. Os dados incluíram ano da coleta da amostra, tipo da amostra, microrganismos isolados e seus mecanismos de resistência. Os laudos que continham informações referentes ao início do tratamento do paciente com antimicrobianos foram excluídos. Resultados: No geral, a prevalência de casos positivos correspondentes a bactérias isoladas foi de 39,8% (150/377) em todo o período de estudo. Os menores e maiores índices foram verificados nos anos de 2018 e 2020, respectivamente, sendo que em 2018, nenhuma amostra analisada foi positiva. Em 2019, 44% (4/9) das amostras foram positivas, sendo a Klebsiella pneumoniae carbapenemase (KPC) a mais prevalente, isolada de 75% (3/4) das amostras positivas. Em 2020, 43% (53/122) das amostras foram positivas, sendo a Escherichia coli produtora de β-lactamases de espectro estendido (ESBL) presente em 32% (17/53), seguida de Enterobacter cloacae ESBL e de K. pneumoniae KPC. No ano de 2021, 40% (93/230) das amostras tiveram resultado positivo, sendo a E. coli ESBL a mais prevalente, presente em 57% (53/93) das amostras positivas. Por fim, foi verificada uma maior prevalência de amostras positivas coletadas nos sítios retal e de pele. Considerações finais: O presente estudo evidenciou o aumento de bactérias resistentes em 2020 e 2021, período que coincide com a pandemia de covid-19. Desta forma, é indispensável a implementação de condutas que contribuam para a melhoria do controle de microrganismos resistentes no município.Universidade Federal de Santa Maria2023-03-22info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://periodicos.ufsm.br/revistasaude/article/view/7127710.5902/2236583471277Saúde (Santa Maria); Revista Saúde (Santa Maria). 2022, v. 48, n. 1Saúde (Santa Maria); Revista Saúde (Santa Maria). 2022, v. 48, n. 12236-58340103-4499reponame:Saúde (Santa Maria)instname:Universidade Federal de Santa Maria (UFSM)instacron:UFSMporhttps://periodicos.ufsm.br/revistasaude/article/view/71277/51788Copyright (c) 2023 Genara Cerato Todescatto, Alessandra Lago Salame, Thaís Dalzochioinfo:eu-repo/semantics/openAccessCerato Todescatto, Genara Lago Salame, AlessandraDalzochio, Thaís2023-03-22T13:03:38Zoai:ojs.pkp.sfu.ca:article/71277Revistahttps://periodicos.ufsm.br/revistasaudePUBhttps://periodicos.ufsm.br/revistasaude/oairevistasaude.ufsm@gmail.com || amanda.revsaude@gmail.com || beatriz.revsaude@gmail.com2236-58342236-5834opendoar:2023-03-22T13:03:38Saúde (Santa Maria) - Universidade Federal de Santa Maria (UFSM)false
dc.title.none.fl_str_mv Prevalence and mechanisms of antimicrobial resistance in samples of surveillance swabs from patients in a hospital unit in Nova Prata, RS
PREVALÊNCIA E MECANISMOS DE RESISTÊNCIA ANTIMICROBIANA EM AMOSTRAS DE SWABS DE VIGILÂNCIA DE PACIENTES INTERNADOS EM UMA UNIDADE HOSPITALAR DE NOVA PRATA, RS
title Prevalence and mechanisms of antimicrobial resistance in samples of surveillance swabs from patients in a hospital unit in Nova Prata, RS
spellingShingle Prevalence and mechanisms of antimicrobial resistance in samples of surveillance swabs from patients in a hospital unit in Nova Prata, RS
Cerato Todescatto, Genara
Antimicrobials
Hospital Infection
Bacterial Resistance
Antimicrobianos
Infecção Hospitalar
Resistência bacteriana
title_short Prevalence and mechanisms of antimicrobial resistance in samples of surveillance swabs from patients in a hospital unit in Nova Prata, RS
title_full Prevalence and mechanisms of antimicrobial resistance in samples of surveillance swabs from patients in a hospital unit in Nova Prata, RS
title_fullStr Prevalence and mechanisms of antimicrobial resistance in samples of surveillance swabs from patients in a hospital unit in Nova Prata, RS
title_full_unstemmed Prevalence and mechanisms of antimicrobial resistance in samples of surveillance swabs from patients in a hospital unit in Nova Prata, RS
title_sort Prevalence and mechanisms of antimicrobial resistance in samples of surveillance swabs from patients in a hospital unit in Nova Prata, RS
author Cerato Todescatto, Genara
author_facet Cerato Todescatto, Genara
Lago Salame, Alessandra
Dalzochio, Thaís
author_role author
author2 Lago Salame, Alessandra
Dalzochio, Thaís
author2_role author
author
dc.contributor.author.fl_str_mv Cerato Todescatto, Genara
Lago Salame, Alessandra
Dalzochio, Thaís
dc.subject.por.fl_str_mv Antimicrobials
Hospital Infection
Bacterial Resistance
Antimicrobianos
Infecção Hospitalar
Resistência bacteriana
topic Antimicrobials
Hospital Infection
Bacterial Resistance
Antimicrobianos
Infecção Hospitalar
Resistência bacteriana
description Objective: To analyze the prevalence and the mechanisms of antimicrobial resistance of isolated bacteria (rectal, nasal and skin samples) of patients in a hospital unit in the city of Nova Prata, RS. Methods: Data were collected from 377 reports from the Serviço de Controle de Infecção Hospitalar (SCIH) issued between January 2018 and December 2021 available in the electronic system of a clinical analysis laboratory located in Nova Prata, RS. Data included the year of sample collection, sample type, microorganisms isolated and their resistance mechanisms. Reports that contained information regarding the initiation of the patient's treatment with antimicrobials were excluded. Results: Overall, the prevalence of positive cases corresponding to isolated bacteria was 39.8% (150/377) over the entire study period. The lowest and highest rates were verified in the years 2018 and 2020, respectively, and in 2018, no sample analyzed was positive. In 2019, 44% (4/9) of the samples were positive, and the Klebsiella pneumoniae carbapenemase (KPC) was the most prevalent, being isolated from 75% of the positive samples (3/4). In 2020, 43% (53/122) of the samples were positive, with the Escherichia coli producer of β-lactamases of extended-spectrum (ESBL) present in 32% (17/53), followed by Enterobacter cloacae ESBL and K. pneumoniae carbapenemase. In the year 2021, 40% (93/230) of the samples had a positive result, and the E. coli ESBL was the most prevalent, present in 57% (53/93) of positive samples. Finally, a higher prevalence of positive samples collected from the rectal and skin sites was found. Final considerations: The present study showed an increase in resistant bacteria in 2020 and 2021, which coincides with the covid-19 pandemic. Thus, it is essential to implement procedures that contribute to improving the control of resistant microorganisms in the municipality.
publishDate 2023
dc.date.none.fl_str_mv 2023-03-22
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://periodicos.ufsm.br/revistasaude/article/view/71277
10.5902/2236583471277
url https://periodicos.ufsm.br/revistasaude/article/view/71277
identifier_str_mv 10.5902/2236583471277
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://periodicos.ufsm.br/revistasaude/article/view/71277/51788
dc.rights.driver.fl_str_mv Copyright (c) 2023 Genara Cerato Todescatto, Alessandra Lago Salame, Thaís Dalzochio
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2023 Genara Cerato Todescatto, Alessandra Lago Salame, Thaís Dalzochio
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Federal de Santa Maria
publisher.none.fl_str_mv Universidade Federal de Santa Maria
dc.source.none.fl_str_mv Saúde (Santa Maria); Revista Saúde (Santa Maria). 2022, v. 48, n. 1
Saúde (Santa Maria); Revista Saúde (Santa Maria). 2022, v. 48, n. 1
2236-5834
0103-4499
reponame:Saúde (Santa Maria)
instname:Universidade Federal de Santa Maria (UFSM)
instacron:UFSM
instname_str Universidade Federal de Santa Maria (UFSM)
instacron_str UFSM
institution UFSM
reponame_str Saúde (Santa Maria)
collection Saúde (Santa Maria)
repository.name.fl_str_mv Saúde (Santa Maria) - Universidade Federal de Santa Maria (UFSM)
repository.mail.fl_str_mv revistasaude.ufsm@gmail.com || amanda.revsaude@gmail.com || beatriz.revsaude@gmail.com
_version_ 1799944002756149248